Dark
Light
System
Institutional Investment Manager
Redmile Group, LLC
Redmile Group, LLC (CIK: 0001425738) incorporated in Delaware, located at One Letterman Drive, San Francisco, CA. Institutional holdings reported to the SEC.

Institutional Holdings (2017Q1)
Portfolio Summary: 60 holdings with a total value of $1,540,736,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 CASTLIGHT HEALTH INC COM CL B 10,229 37,000 0.00%
2 ADVERUM BIOTECHNOLOGIES INC 22,236 60,000 0.00%
3 AMEDISYS INC COM 4,826 247,000 0.02%
4 UNITEDHEALTH GROUP INC 1,820 298,000 0.02%
5 AURINIA PHARMACEUTICALS INC 140,243 1,029,000 0.07%
6 RA PHARMACEUTICALS INC COM 110,769 2,358,000 0.15%
7 ACLARIS THERAPEUTICS INC COM 90,700 2,705,000 0.18%
8 AVEXIS INC COM 45,349 3,448,000 0.22%
9 SURGERY PARTNERS INCORPORATED 303,500 5,918,000 0.38%
10 DYNAVAX TECHNOLOGIES CORP 1,019,491 6,066,000 0.39%
11 FATE THERAPEUTICS INC 1,419,058 6,457,000 0.42%
12 ProQR Therapeutics NV 1,553,225 7,766,000 0.50%
13 MODEL N INCORPORATED 822,314 8,593,000 0.56%
14 INVITAE CORP 812,240 8,983,000 0.58%
15 CHARLES RIV LABS INTL INC 121,307 10,912,000 0.71%
16 MCKESSON CORP 78,300 11,609,000 0.75%
17 CYTOMX THERAPEUTICS INC COM 681,892 11,776,000 0.76%
18 ARRAY BIOPHARMA INC 3 06/01/2020 9,000,000 12,763,000 0.83% PRN
19 Audentes Therapeutics, Inc. 820,836 13,987,000 0.91%
20 EHEALTH INC COM 1,191,334 14,344,000 0.93%
21 SYROS PHARMACEUTICALS INC 952,740 15,177,000 0.99%
22 IMMUNOGEN INC 3,984,734 15,421,000 1.00%
23 BLUEPRINT MEDICINES CORP COM 400,000 15,996,000 1.04%
24 SPECTRANETICS CORP 557,189 16,228,000 1.05%
25 PAREXEL INTERNATIONAL CORPORATION 260,231 16,423,000 1.07%
26 CASCADIAN THERAPEUTICS INC 4,072,424 16,860,000 1.09%
27 CATALENT INC 624,000 17,672,000 1.15%
28 LA JOLLA PHARMACEUTICAL CO 604,470 18,043,000 1.17%
29 NANOSTRING TECHNOLOGIES INC 934,424 18,567,000 1.21%
30 EXPRESS SCRIPTS HLDG CO 293,807 19,365,000 1.26%
31 ENDOLOGIX INC 2,717,394 19,674,000 1.28%
32 DIPLOMAT PHARMACY INC COM 1,254,342 20,007,000 1.30%
33 PATHEON N V 826,843 21,779,000 1.41%
34 IMMUNOMEDICS INCORPORATED 3,380,846 21,874,000 1.42%
35 JOUNCE THERAPEUTICS INC 1,114,160 22,523,000 1.46%
36 REGENXBIO INC COM 1,269,131 24,494,000 1.59%
37 ICU MED INC 160,543 24,515,000 1.59%
38 NEURODERM LTD 924,304 24,540,000 1.59%
39 NEUROCRINE BIOSCIE COM USD0.001 622,345 26,948,000 1.75%
40 CHIMERIX INC 4,325,055 27,594,000 1.79%
41 ANTHEM INC 175,328 28,996,000 1.88%
42 INC RESH HLDGS INC 633,779 29,059,000 1.89%
43 BOSTON SCIENTIFIC CORP 1,200,099 29,846,000 1.94%
44 Oxford Immunotec Global PLC 2,004,849 31,055,000 2.02%
45 GLOBAL BLOOD THERAPEUTICS INCORPORATED 934,343 34,431,000 2.23%
46 WAVE LIFE SCIENCES LTD 1,271,097 34,955,000 2.27%
47 XENCOR INC COM 1,592,526 38,093,000 2.47%
48 ALDER BIOPHARMACEUTICALS INC 1,909,886 39,726,000 2.58%
49 GW PHARMACEUTICALS PLC 332,544 40,218,000 2.61%
50 INCYTE CORP 307,723 41,133,000 2.67%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-17-000012, filed 2017.05.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.